(Q40484626)

20 September 2017

title

Chemosensitization by erythropoietin through inhibition of the NF-kappaB rescue pathway (English)

1 reference

20 September 2017

0 references

1 reference

10

Guido Kroemer

1 reference

Marie-Françoise Bourgeade

20 September 2017

7

object named as

Marie-Françoise Bourgeade

1 reference

20 September 2017

Gabrielle Carvalho

1

1 reference

20 September 2017

Carmen Lefaucheur

2

1 reference

20 September 2017

Claire Cherbonnier

3

1 reference

20 September 2017

Didier Métivier

4

1 reference

20 September 2017

Alain Chapel

5

1 reference

20 September 2017

Marc Pallardy

6

1 reference

20 September 2017

Bernard Charpentier

8

1 reference

20 September 2017

François Hirsch

9

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

20 September 2017

1 reference

20 September 2017

volume

24

1 reference

20 September 2017

issue

5

1 reference

20 September 2017

page(s)

737-745

1 reference

Use of erythropoietin in cancer patients: assessment of oncologists' practice patterns in the United States and other countries

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

The NF-kappa B and I kappa B proteins: new discoveries and insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

Haemopoietic receptors and helical cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

Evidence for a role of NF-kappaB in the survival of hematopoietic cells mediated by interleukin 3 and the oncogenic TEL/platelet-derived growth factor receptor beta fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

Erythropoietin-dependent transformation of myelodysplastic syndrome to acute monoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

Quantitation of mitochondrial alterations associated with apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

Potentiation of tumour apoptosis by human growth hormone via glutathione production and decreased NF-kappaB activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

Human growth hormone gene transfer into tumor cells may improve cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

Chemotherapy: targeting the mitochondrial cell death pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

Antibody-mediated endocytosis of G250 tumor-associated antigen allows targeted gene transfer to human renal cell carcinoma in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

Erythropoietin as an antiapoptotic, tissue-protective cytokine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

The Rel/NF-kappaB signal transduction pathway: introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

Cell damage-induced conformational changes of the pro-apoptotic protein Bak in vivo precede the onset of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

Proteasome inhibitor PS-341 abrogates IL-6 triggered signaling cascades via caspase-dependent downregulation of gp130 in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

NF-kappaB in cancer: from innocent bystander to major culprit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

NF-kappaB at the crossroads of life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

Derivatives of erythropoietin that are tissue protective but not erythropoietic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

The effects of anemia in hematologic malignancies: more than a symptom

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

RNA interference in adult mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

Erythropoietin has an anti-myeloma effect - a hypothesis based on a clinical observation supported by animal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

Conformation of the Bax C-terminus regulates subcellular location and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

Jak2 is essential for signaling through a variety of cytokine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

NF-kappaB and p53 are the dominant apoptosis-inducing transcription factors elicited by the HIV-1 envelope

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

A phase 2 study of bortezomib in relapsed, refractory myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

A multicenter retrospective cohort study of practice patterns and clinical outcomes of the use of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

The NF-kappaB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

Erythropoietin receptor in myelodysplastic syndrome and leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

Erythropoietin regulates tumour growth of human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

Rapid and reversible relocalization of heat shock factor 1 within seconds to nuclear stress granules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

inferred from DOI database lookup

7 January 2021

based on heuristic

Repression of NF-kappaB impairs HeLa cell proliferation by functional interference with cell cycle checkpoint regulators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208205

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1208205

1 reference

Dimensions Publication ID

20 September 2017

1041258491

0 references

1 reference